ENTRIES TAGGED "BioCoder"
Synthetic biology surely can get weirder — but this is a great start.
If you’ve ever tried any of the various vegan cheese substitutes, they are (to put it kindly) awful. The missing ingredient in these products is the milk proteins, or caseins. And of course you can’t use real milk proteins in a vegan product.
But proteins are just organic compounds that are produced, in abundance, by any living cell. And synthetic biology is about engineering cell DNA to produce whatever proteins we want. That’s the central idea behind the Real Vegan Cheese project: can we design yeast to produce the caseins we need for cheese, without involving any animals? There’s no reason we can’t. Once we have the milk proteins, we can use traditional processes to make the cheese. No cows (or sheep, or goats) involved, just genetically modified yeast. And you never eat the yeast; they stay behind at the brewery.
Joe Schloendorn is creating and distributing plasmids that can freely be reproduced — a huge breakthrough for DIY bio.
At O’Reilly, we’ve long been supporters of the open source movement — perhaps not with the religious fervor of some, but with a deep appreciation for how open source has transformed the computing industry over the last three decades.
We also have a deep appreciation for the dangers that closed source, restrictive licenses, patent trolling, and other technocratic evils pose to areas that are just opening up — biology, in particular. So it is with great interest that I read Open Source Biotech Consumables in the latest issue of BioCoder.
I’m not going to rehash the article; you should read it yourself. The basic argument is that some proteins used in research cost thousands of dollars per milligram. They’re easily reproducible (we’re talking DNA, after all), but frequently tied up with restrictive licenses. In addition, many of the vendors will only sell to research institutions and large corporations, not home labs or small community labs. So, Joe Schloendorn is creating and distributing plasmids that can freely be reproduced. That in itself is a huge breakthrough.
Inside this issue: implanting evolution, open source biotech consumables, power supplies for systems biology, and more.
We’ve made it to our fourth issue of BioCoder! I’m excited about this issue — it’s the best collection of articles we’ve published so far.
Some of the highlights are:
- Implanting Evolution:
- We spend a lot of time thinking about how to modify other creatures, from microbes on up. What about ourselves? Surgeons already implant pacemakers and insulin pumps into humans. What about other applications? What are the possibilities if you implant NFC and RFID chips?
- Open Source Biotech Consumables:
- One of the biggest problems for grassroots biotech research is the price of ingredients. Some proteins cost thousands of dollars per milligram, hardly affordable by a community lab or a small startup. We can solve that problem with “open source” DNA. This is an exciting development — and a challenge to what we mean by “open source” (I promise to write about that in another post).
Solid's long view includes biology as part of the creator's toolkit.
Tim O’Reilly subjected himself to an engaging Ask Me Anything session on Reddit earlier this week. The focus of the exchange was the Internet of Things, in anticipation of our Solid conference taking place next month.
We’re always listening for faint signals from our community about what they’re getting interested in, and one area that’s stood out to us is biology, which is becoming easier to experiment with at home, as a hobbyist, and through hackerspaces like Biocurious and Genspace. You’ll find a few threads on biology at Solid this year, but we’ve tagged it to be a little more central at Solid 2015. Beyond the hobbyist and health-related applications, we see synthetic biology as another way to translate between virtual and physical, like 3D printers and stereoscopic cameras.
Here’s an exchange from Tuesday’s Reddit thread that sums it up nicely.
What prompted the start of BioCoder? Are people really doing biotech in their garages in the same way that many computer hardware and software innovations happened?
Hacking lab equipment to make it programmable is a good first step toward lab automation.
In the new issue of BioCoder, Peter Sand writes about Hacking Lab Equipment. It’s well worth a read: it gives a number of hints about how standard equipment can be modified so that it can be controlled by a program. This is an important trend I’ve been watching on a number of levels, from fully robotic labs to much more modest proposals, like Sand’s, that extend programmability even to hacker spaces and home labs.
In talking to biologists, I’m surprised at how little automation there is in research labs. Automation in industrial labs, the sort that process thousands of blood and urine samples per hour, yes: that exists. But in research labs, undergrads, grad students, and post-docs spend countless hours moving microscopic amounts of liquid from one place to another. Why? It’s not science; it’s just moving stuff around. What a waste of mental energy and creativity.
Lab automation, though, isn’t just about replacing countless hours of tedium with opportunities for creative thought. I once talked to a system administrator who wrote a script for everything, even for only a simple one-liner. (Might have been @yesthattom, I don’t remember.) This practice is based on an important insight: writing a script documents exactly what you did. You don’t have to think about, “oh, did I add the f option on that rm -r / command?”; you can just look. If you need to do the same thing on another system, you can reproduce what you did exactly.
There's good reason to believe nature has clues about how to do a good job — can it also help with web designs?
A couple of years ago, I visited the World Science Festival in New York and saw Festo’s robotic bird. It was amazing. I’ve seen things that looked more or less like a bird, and that flew, but clearly weren’t flying like a bird. An airplane has a body, has wings, and flies, but you wouldn’t mistake it for a bird. This was different: it looked like a giant seagull, with head and tail movements that were clearly modelled on a living bird’s.
Since then, Festo has built a robotic kangaroo; based on work they started in 2010, they have a robotic elephant’s trunk that learns, a robotic jellyfish, and no doubt many other animals that I haven’t yet seen.
Advances in biology and biotechnology are driving us in exciting new directions — be part of the revolution!
We’re excited about the third issue of BioCoder, O’Reilly’s newsletter about the revolution in biology and biotechnology. In the first article of our new issue, Ryan Bethencourt asks the question “What does Biotechnology Want?” Playing with Kevin Kelly’s ideas about how technological development drives human development, Bethencourt asks about the directions in which biotechnology is driving us. We’re looking for a new future with significant advances in agriculture, food, health, environmental protection, and more.
That future will be ours — if we choose to make it. Bethencourt’s argument (and Kelly’s) is that we can’t not choose to make it. Yes, there are plenty of obstacles: the limits to our understanding of biology and genetics, the inadequate tools we have for doing research, the research institutions themselves, and even fear of the future. We’ll overcome these obstacles; indeed, if Bethencourt is right, and biology is our destiny, we have no choice but to overcome these obstacles. The only question is whether you’re part of the revolution or not.
In the future, we will solve biological problems by running experiments in parallel.
Perhaps the most ambitious project right now is Synbiota’s #ScienceHack. They are organizing a large number of volunteer groups to experiment with techniques to produce the compound Violacein. Violacein is potentially useful as an anti-cancer and anti-dysentery drug, but currently costs $356,000 per gram to produce. This price makes research (to say nothing of therapeutic use) impossible. However, it’s possible that bacteria can be genetically engineered to produce Violacein much more efficiently and cheaply. That’s what the #ScienceHack experiment is about: the groups will be trying to design DNA that can be inserted into E. coli bacteria to make it produce Violacein at a fraction of the cost. Read more…
Natural bioterrorism might be the bigger threat, and the value of citizens educated in biosciences can't be overstated.
You don’t get very far discussing synthetic biology and biohacking before someone asks about bioterrorism. So, let’s meet the monster head-on.
I won’t downplay the possibility of a bioterror attack. It’s already happened. The Anthrax-contaminated letters that were sent to political figures just after 9/11 were certainly an instance of bioterrorism. Fortunately (for everyone but the victims), they only resulted in five deaths, not thousands. Since then, there have been a few “copycat” crimes, though using a harmless white powder rather than Anthrax spores.
While I see bioterror in the future as a certainty, I don’t believe it will come from a hackerspace. The 2001 attacks are instructive: the spores were traced to a U.S. biodefense laboratory. Whether or not you believe Bruce Ivins, the lead suspect, was guilty, it’s clear that the Anthrax spores were developed by professionals and could not have been developed outside of a professional setting. That’s what I expect for future attacks: the biological materials, whether spores, viruses, or bacteria, will come from a research laboratory, produced with government funding. Whether they’re stolen from a U.S. lab or produced overseas: take your pick. They won’t come from the hackerspace down the street. Read more…
Jim Stogdill, Jon Bruner, and Mike Loukides chat about personalizing all the things.
This week in our Radar podcast, Jon and I both had colds. You’ll be pleased to know that I edited out all the sneezes, coughs, and general upper respiratory mayhem, but unfortunately there is no Audacity filter for a voice that sounds like a frog caught in a mouse trap (mine). If that hasn’t dissuaded you from listening, we covered some things that were really interesting, at least to us.
Here are some links to things you’ll hear in this episode:
Blackberry’s salvation may reside in its QNX embedded systems division.
The Pennsylvania Railroad was an amazing technical organization in its heyday. Railroads were that time’s web, and Pennsylvania was its Google. It created a lot of the practices we still use today for testing and other technical disciplines. Also, I suppose if Atlas were to shrug today (shudder) John Galt would be a data center designer. Read more…